The Times Australia
Fisher and Paykel Appliances
The Times World News

.

Why cough medicines containing pholcodine can be deadly even if you took them months before surgery

  • Written by Nial Wheate, Associate Professor of the Sydney Pharmacy School, University of Sydney
Why cough medicines containing pholcodine can be deadly even if you took them months before surgery

Cough medicines containing the active ingredient pholcodine are being withdrawn from sale due to safety concerns highlighted for years both in Australia and internationally.

Yesterday, Australia’s medicines regulator announced[1] the immediate registration cancellation and recall of dozens of these over-the-counter cough medicines and lozenges.

This is because of the risk of a sudden, severe and life-threatening allergic reaction if people are also given specific muscle relaxant drugs while under a general anaesthetic.

That risk of anaphylaxis can remain weeks and months after taking the cough medicine.

Read more: Still coughing after COVID? Here's why it happens and what to do about it[2]

What is pholcodine?

Pholcodine (pronounced pho-co-dean) is an opioid-based medicine, which means it’s related to morphine and codeine. It works by binding to various opioid receptors in a part of the brain responsible for triggering the cough reflex.

As such, it is a common ingredient in many over-the-counter medicines used to treat a dry cough[3]. These include cough syrups and lozenges. Every product that contains pholcodine will list it prominently on the bottle or cardboard packaging.

Common brands that contain this ingredient include Benadryl, Bisolvon, Codral, Difflam, Difflam Plus and Duro-Tuss.

Read more: Sore throats suck. Do throat lozenges help at all?[4]

Why the recall?

The most common side effects of pholcodine are dizziness, nausea and sedation. But the Therapeutic Goods Administration (TGA) has recalled products containing it, as pholcodine can trigger anaphylaxis around the time of surgery.

The issue arises when pholcodine medicines are combined with types of muscle relaxants given during surgery known as neuromuscular blocking agents[5].

This type of anaphylaxis can occur in people who have had a muscle relaxant before and been previously fine, or in people who receive a muscle relaxant drug for the first time.

Being obese[6] also places people at higher risk of this type of anaphylaxis.

Person under anesthesia during surgery, gas mask over face
Muscle relaxants given during surgery plus pholcodine can be a lethal mix. Shutterstock[7]

Read more: Cough syrup can harm children: experts warn of contamination risks[8]

We’ve known about the risk for years

We have actually known about the risks of pholcodine and muscle relaxants for some time, including in Scandinavian studies[9] in 2005.

In fact, it was because of these studies that pholcodine was withdrawn from the market in Norway in 2007[10].

The European Medicines Agency recommended the withdrawal of pholcodine[11] in Europe in December 2022.

In Australia, the PatientSafe Network[12] has been calling for its ban since at least 2017.

Over the past 12 months, there were nine reported cases of serious adverse effects to pholcodine reported to the TGA, including three deaths. The most recent case was in January this year. In three of the nine, pholcodine was the only suspected medicine involved.

Some common products affected by the recall These common cough syrups and lozenges are among products being recalled. Author provided

Why now?

The TGA’s decision may come from a recent (but not yet peer reviewed) French study[13]. This found that when patients had taken pholcodine at any time in the 12 months before surgery that used a muscle relaxant, they were at much higher risk of anaphylaxis.

The French research is consistent with an earlier Western Australian study[14] which found anaphylaxis is 14 times more likely to occur when the two types of drugs are combined.

This is because pholcodine can linger in the body for long periods. After you swallow the medicine, the drug reaches its highest concentration in the blood stream one to two hours later[15]. But both the drug and its metabolites can still be detected in the body up to seven weeks later[16].

I have some at home. What now?

As pholcodine can linger in the body, the TGA has warned that if you have taken a medicine containing pholcodine in the past 12 months you need to tell your doctor before you have surgery.

If you are taking one of these medicines you should stop immediately, even if you don’t think you’re going to have a medical procedure soon.

Take it to your local pharmacy for disposal. At that time, the pharmacist will be able to recommend a different medicine[17] for your cough.

Read more: Health Check: do cough medicines work?[18]

References

  1. ^ announced (www.tga.gov.au)
  2. ^ Still coughing after COVID? Here's why it happens and what to do about it (theconversation.com)
  3. ^ dry cough (www.healthdirect.gov.au)
  4. ^ Sore throats suck. Do throat lozenges help at all? (theconversation.com)
  5. ^ neuromuscular blocking agents (www.cec.health.nsw.gov.au)
  6. ^ obese (www.sciencedirect.com)
  7. ^ Shutterstock (www.shutterstock.com)
  8. ^ Cough syrup can harm children: experts warn of contamination risks (theconversation.com)
  9. ^ Scandinavian studies (onlinelibrary.wiley.com)
  10. ^ in 2007 (onlinelibrary.wiley.com)
  11. ^ the withdrawal of pholcodine (www.ema.europa.eu)
  12. ^ PatientSafe Network (www.psnetwork.org)
  13. ^ study (www.medrxiv.org)
  14. ^ Western Australian study (www.sciencedirect.com)
  15. ^ one to two hours later (www.ncbi.nlm.nih.gov)
  16. ^ up to seven weeks later (www.medsafe.govt.nz)
  17. ^ different medicine (theconversation.com)
  18. ^ Health Check: do cough medicines work? (theconversation.com)

Read more https://theconversation.com/why-cough-medicines-containing-pholcodine-can-be-deadly-even-if-you-took-them-months-before-surgery-200895

Times Magazine

Can bigger-is-better ‘scaling laws’ keep AI improving forever? History says we can’t be too sure

OpenAI chief executive Sam Altman – perhaps the most prominent face of the artificial intellig...

A backlash against AI imagery in ads may have begun as brands promote ‘human-made’

In a wave of new ads, brands like Heineken, Polaroid and Cadbury have started hating on artifici...

Home batteries now four times the size as new installers enter the market

Australians are investing in larger home battery set ups than ever before with data showing the ...

Q&A with Freya Alexander – the young artist transforming co-working spaces into creative galleries

As the current Artist in Residence at Hub Australia, Freya Alexander is bringing colour and creativi...

This Christmas, Give the Navman Gift That Never Stops Giving – Safety

Protect your loved one’s drives with a Navman Dash Cam.  This Christmas don’t just give – prote...

Yoto now available in Kmart and The Memo, bringing screen-free storytelling to Australian families

Yoto, the kids’ audio platform inspiring creativity and imagination around the world, has launched i...

The Times Features

Why the Mortgage Industry Needs More Women (And What We're Actually Doing About It)

I've been in fintech and the mortgage industry for about a year and a half now. My background is i...

Inflation jumps in October, adding to pressure on government to make budget savings

Annual inflation rose[1] to a 16-month high of 3.8% in October, adding to pressure on the govern...

Transforming Addiction Treatment Marketing Across Australasia & Southeast Asia

In a competitive and highly regulated space like addiction treatment, standing out online is no sm...

Aiper Scuba X1 Robotic Pool Cleaner Review: Powerful Cleaning, Smart Design

If you’re anything like me, the dream is a pool that always looks swimmable without you having to ha...

YepAI Emerges as AI Dark Horse, Launches V3 SuperAgent to Revolutionize E-commerce

November 24, 2025 – YepAI today announced the launch of its V3 SuperAgent, an enhanced AI platf...

What SMEs Should Look For When Choosing a Shared Office in 2026

Small and medium-sized enterprises remain the backbone of Australia’s economy. As of mid-2024, sma...

Anthony Albanese Probably Won’t Lead Labor Into the Next Federal Election — So Who Will?

As Australia edges closer to the next federal election, a quiet but unmistakable shift is rippli...

Top doctors tip into AI medtech capital raise a second time as Aussie start up expands globally

Medow Health AI, an Australian start up developing AI native tools for specialist doctors to  auto...

Record-breaking prize home draw offers Aussies a shot at luxury living

With home ownership slipping out of reach for many Australians, a growing number are snapping up...